• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

20例II型和III型α/β型黏脂贮积症中国先证者的临床和分子特征

Clinical and molecular characteristics of 20 Chinese probands with Mucolipidosis type II and III alpha/beta.

作者信息

Feng Yuyu, Huang Yonglan, Zhao Xiaoyuan, Sheng Huiying, Su Xueying, Yin Xi, Li Liu, Zhang Wen

机构信息

Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9 Jinsui Road, Guangzhou, 510623, China.

出版信息

BMC Pediatr. 2024 Dec 23;24(1):830. doi: 10.1186/s12887-024-05223-x.

DOI:10.1186/s12887-024-05223-x
PMID:39710647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11665131/
Abstract

BACKGROUND

Mucolipidosis (ML) II and III alpha/beta are lysosomal disorders caused by mutations in the GNPTAB gene which encodes the alpha and beta subunits of the heterohexameric enzyme, N-acetylglucosamine-1-phosphotransferase.

METHOD

To explore the clinical and molecular characteristics of the 20 ML II and III alpha/beta patients, clinical data was collected and GNPTAB gene was analyzed by nest PCR and direct Sanger-sequencing. The activity of several lysosomal enzymes was measured in the plasma.

RESULTS

Among the 20 ML II and III alpha/beta patients, 6 patients were classified as ML II and 14 as ML III alpha/beta. The main clinical manifestations were joint stiffness, skeletal deformity, mental retardation and short stature. Bone X-ray examination showed radiological changes. The plasma arylsulfatase A and hexosaminidase A enzyme activities increased significantly. Urinary glycosaminoglycan values were normal. We detected mutations in GNPTAB in 35 of 40 alleles (87.5%). Mutation c.2715 + 1G > A and c.2404 C > T (p.Gln802Ter) were the most prevalent variants, accounting for 14.3% and 11.4%, respectively. Five novel mutations c.3335 + 5G > A, c.1284 + 1G > A, c.571 + 4 A > G, c.1634_1635delAA (p.Lys545Serfs*16) and c.1582T > C(p.Cys528Arg) were identified.

CONCLUSION

Our study expands the spectrum of GNPTAB gene in China. Mutation c.2715 + 1G > A was the most prevalent mutation in our study. The novel mutation c.1284 + 1G > A might be a severe mutation associated with ML II.

摘要

背景

黏脂贮积症(ML)II型和III型α/β型是由GNPTAB基因突变引起的溶酶体疾病,该基因编码异源六聚体酶N-乙酰葡糖胺-1-磷酸转移酶的α和β亚基。

方法

为探究20例ML II型和III型α/β型患者的临床和分子特征,收集临床数据并通过巢式PCR和直接桑格测序法分析GNPTAB基因。检测血浆中几种溶酶体酶的活性。

结果

在20例ML II型和III型α/β型患者中,6例被归类为ML II型,14例为ML III型α/β型。主要临床表现为关节僵硬、骨骼畸形、智力发育迟缓及身材矮小。骨骼X线检查显示有影像学改变。血浆芳基硫酸酯酶A和己糖胺酶A的酶活性显著升高。尿糖胺聚糖值正常。我们在40个等位基因中的35个(87.5%)检测到GNPTAB基因突变。突变c.2715+1G>A和c.2404 C>T(p.Gln802Ter)是最常见的变异,分别占14.3%和11.4%。鉴定出5种新突变,即c.3335+5G>A、c.1284+1G>A、c.571+4 A>G、c.1634_1635delAA(p.Lys545Serfs*16)和c.1582T>C(p.Cys528Arg)。

结论

我们的研究扩展了中国GNPTAB基因的突变谱。突变c.2715+1G>A是我们研究中最常见的突变。新突变c.12

相似文献

1
Clinical and molecular characteristics of 20 Chinese probands with Mucolipidosis type II and III alpha/beta.20例II型和III型α/β型黏脂贮积症中国先证者的临床和分子特征
BMC Pediatr. 2024 Dec 23;24(1):830. doi: 10.1186/s12887-024-05223-x.
2
Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.鉴定中国东部地区 II/III 型黏脂贮积症患者中 GNPTAB 基因的主要突变及 II 型黏脂贮积症的产前诊断。
Acta Pharmacol Sin. 2019 Feb;40(2):279-287. doi: 10.1038/s41401-018-0023-9. Epub 2018 Jun 5.
3
Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis.韩国黏脂贮积症II/III型患者的临床、生化及分子特征分析与成功的产前诊断
Orphanet J Rare Dis. 2017 Jan 17;12(1):11. doi: 10.1186/s13023-016-0556-2.
4
GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.黏脂贮积症 III α/β 型患者中 GNPTAB 基因 c.2404C>T 无义突变:病例报告
BMC Med Genet. 2018 Sep 12;19(1):162. doi: 10.1186/s12881-018-0679-5.
5
Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.13例II型或III型粘脂贮积症患者GNPTAB和GNPTG基因的分子分析——鉴定出8个新突变
Clin Genet. 2009 Jul;76(1):76-84. doi: 10.1111/j.1399-0004.2009.01185.x.
6
Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.三种新型 GNPTG 基因突变导致 III 型黏脂贮积症γ。
Gene. 2014 Feb 10;535(2):294-8. doi: 10.1016/j.gene.2013.11.010. Epub 2013 Dec 6.
7
Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.黏脂贮积症II型(I型细胞病)和黏脂贮积症IIIA型(典型的假胡尔勒多营养不良症)是由N-乙酰葡糖胺磷酸转移酶α/β亚基前体基因突变引起的。
Am J Hum Genet. 2006 Mar;78(3):451-63. doi: 10.1086/500849. Epub 2006 Jan 24.
8
Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA.在患有II型或IIIA型粘脂贮积症的韩国患者中鉴定编码N-乙酰葡糖胺磷酸转移酶α/β亚基的GNPTA(MGC4170)基因突变。
Hum Mutat. 2005 Oct;26(4):308-14. doi: 10.1002/humu.20205.
9
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.黏脂贮积症 II 型和 III 型 alpha/beta 的表型和基因型:61 例先证者的研究。
J Med Genet. 2010 Jan;47(1):38-48. doi: 10.1136/jmg.2009.067736. Epub 2009 Jul 16.
10
The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.溶酶体贮积症 II 型、III 型α/β和 III 型γ:GNPTAB 和 GNPTG 突变的最新进展。
Hum Mutat. 2019 Jul;40(7):842-864. doi: 10.1002/humu.23748. Epub 2019 Apr 13.

本文引用的文献

1
GCAF(TMEM251) regulates lysosome biogenesis by activating the mannose-6-phosphate pathway.GCAF(TMEM251)通过激活甘露糖-6-磷酸途径来调节溶酶体生物发生。
Nat Commun. 2022 Sep 12;13(1):5351. doi: 10.1038/s41467-022-33025-1.
2
Structures of the mannose-6-phosphate pathway enzyme, GlcNAc-1-phosphotransferase.甘露糖-6-磷酸途径酶,GlcNAc-1-磷酸转移酶的结构。
Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2203518119. doi: 10.1073/pnas.2203518119. Epub 2022 Aug 8.
3
Mucolipidosis type II and type III: a systematic review of 843 published cases.
黏脂贮积症 II 型和 III 型:843 例已发表病例的系统评价。
Genet Med. 2021 Nov;23(11):2047-2056. doi: 10.1038/s41436-021-01244-4. Epub 2021 Jun 25.
4
MutationTaster2021.MutationTaster2021.
Nucleic Acids Res. 2021 Jul 2;49(W1):W446-W451. doi: 10.1093/nar/gkab266.
5
[A novel compound heterozygous mutation of GNPTAB gene underlying a case with mucolipidosis type II α/β].[黏脂贮积症II型α/β一例中GNPTAB基因的一种新型复合杂合突变]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Jun 10;36(6):606-609. doi: 10.3760/cma.j.issn.1003-9406.2019.06.019.
6
Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.鉴定中国东部地区 II/III 型黏脂贮积症患者中 GNPTAB 基因的主要突变及 II 型黏脂贮积症的产前诊断。
Acta Pharmacol Sin. 2019 Feb;40(2):279-287. doi: 10.1038/s41401-018-0023-9. Epub 2018 Jun 5.
7
Mutation Analysis of 16 Mucolipidosis II and III Alpha/Beta Chinese Children Revealed Genotype-Phenotype Correlations.对16名黏脂贮积症II型和III型α/β型中国儿童的突变分析揭示了基因型与表型的相关性。
PLoS One. 2016 Sep 23;11(9):e0163204. doi: 10.1371/journal.pone.0163204. eCollection 2016.
8
A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth.一例Ⅱ型粘脂贮积症,产前出现骨骼发育异常,出生时伴有严重继发性甲状旁腺功能亢进。
Korean J Pediatr. 2012 Nov;55(11):438-44. doi: 10.3345/kjp.2012.55.11.438. Epub 2012 Nov 23.
9
Diagnostic strategy for mucolipidosis II/III.黏脂贮积症 II/III 的诊断策略。
Indian Pediatr. 2012 Dec;49(12):975-7. doi: 10.1007/s13312-012-0247-6. Epub 2012 Jun 10.
10
Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction.甘露糖-6-磷酸途径:对其在溶酶体功能和功能障碍中的作用的综述。
Mol Genet Metab. 2012 Apr;105(4):542-50. doi: 10.1016/j.ymgme.2011.12.012. Epub 2011 Dec 23.